Browse > Article
http://dx.doi.org/10.14480/JM.2021.19.1.23

Anti-hyperlipidemic and anti-obesity effects of Sparassis latifolia fruiting bodies in high-fat and cholesterol-diet-induced hyperlipidemic rats  

Im, Kyung-Hoan (Division of Life Sciences, Incheon National University (Songdo-dong))
Baek, Seung-A (Division of Life Sciences, Incheon National University (Songdo-dong))
Choi, Jaehyuk (Division of Life Sciences, Incheon National University (Songdo-dong))
Lee, Tae-Soo (Division of Life Sciences, Incheon National University (Songdo-dong))
Publication Information
Journal of Mushroom / v.19, no.1, 2021 , pp. 23-32 More about this Journal
Abstract
This study investigated the anti-hyperlipidemic and anti-obesity effects of Sparassis latifolia (S. latifolia) fruiting body powder in rats fed with a high fat and cholesterol diet (HFD). Rats were fed a normal control diet (ND), an HFD, an HFD supplemented with 5% fruiting body powder of S. latifolia (HFD+SL), or an HFD supplemented with 0.03% simvastatin (HFD+SS), for 6 weeks. The HFD group demonstrated considerable increase in body weight gain, the food efficiency ratio (FER), and plasma cholesterol and triglyceride levels, compared to the ND group. In contrast, the HFD+SL and HFD+SS groups showed significantly reduced body weight gain, food intake, and plasma cholesterol and triglyceride levels compared to the HFD group. In particular, the HFD+SL and HFD+SS diets significantly suppressed the occurrence of non-alcoholic fat deposits in the liver. Taken together, these results suggest that dietary supplementation of the fruiting body powder of S. latifolia in an HFD could lower the risks of hyperlipidemia, atherogenesis, and obesity and may be used as a functional food to manage cardiovascular disease and fecal lipid and cholesterol levels.
Keywords
Hypolipidemia; Lipid profile; Obesity; Sparassis latifolia; Steatosis;
Citations & Related Records
Times Cited By KSCI : 4  (Citation Analysis)
연도 인용수 순위
1 Choi MH, Han HK, Lee YJ, Jo HG, Shin HJ. 2014. In vitro anticancer activity of hydrophobic fractions of Sparassis latifolia extract using AGS, A529, and HepG2 cell lines. J Mushroom 12: 304-310.   DOI
2 Dai YC, Wang Z, Binder M, Hibbett DS. 2006. Phylogeny and a new species of Sparassis (Polyporales, Basidiomycota): Evidence from mitochondrial atp6, nuclear rDNA and rpb2 genes. Mycologia 98: 584-592.   DOI
3 Folch J, Lees M, Sloane Stanley GH. 1957. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 226: 497-509.   DOI
4 Gordon DT. 1992. The importance of total dietary fiber in human nutrition and health. Kor J Nutr 25: 75-83.
5 Lee MA, Park JK, Um MH, Jeon JW, Lee JM, Park YK. 2012. Lipolytic effect of Sparassis crispa extracts in differentiated 3T3-L1 cells and high fat diet-induced obese mice. J Korean Soc Food Sci Nutr 41: 1708-1715.   DOI
6 Lee MR, Hou JG, Begum S, Wang YB, Oh DS, Wi AJ, Yoon BS, Sung CK. 2014. Anti-obesity effects of Sparassis crispa on high-fat diet-induced obese mice. J Life Sci 24: 952-958.   DOI
7 Lichtenstein AH, Appel LJ, Brands M, Carnethon M, Daniels S, Franch HA. 2006. Diet and lifestyle recommendations revision 2006: A scientific statement from the American Heart Association Nutrition Committee. Circulation 114: 82-96.   DOI
8 Liu S, Stampfer MJ, Hu FB. 1999. Whole-grain consumption and risk of coronary heart disease: Results from the nurses' health study. Am J Clin Nutr 70: 412-419.   DOI
9 Mori K, Kobayashi C, Tomita T, Inatomi S, Ikeda M. 2008. Antiatherosclerotic effect of the edible mushrooms Pleurotus eryngii (Eringi), Grifola frondosa (Maitake), and Hypsizygus marmoreus (Bunashimeji) in apolipoprotein E-deficient mice. Nutr Res 28: 335-342.   DOI
10 Moradali MF, Mostafavi H, Ghods S, Hedjaroude GA. 2007. Immunomodulating and anticancer agents in the realm of macromycetes fungi (macrofungi). Int Immunopharmacol 7: 701-724.   DOI
11 Ngoc L, Oh YK, Lee YJ, Lee YC. 2018. Effects of Sparassis crispa in medical therapeutics: A systematic review and meta-analysis of randomized controlled trials. Int J Mol Sci 19: 1487. doi:10.3390/ijms19051487.   DOI
12 Ma X, Li Z. 2006. Pathogenesis of nonalcoholic steatohepatitis (NASH). Chin J Dig Dis 7: 7-11.   DOI
13 Qu L, Xin H, Zheng G, Su Y, Ling C. 2012. Hepatoprotective activity of the total saponin from Actinidia valvata Dunn root against carbon tetrachloride-induced liver damage in mice. Evid Based Complement Alternat Med 216061.
14 Yamamoto K, Kimura T, Sugitachi A, Matsuura N. 2009. Antiangiogenic and anti-metastatic effect of β-1,3-D-glucan purified from hanabiratake, Sparassis crispa. Biol Pharm Bull 32: 259-263.   DOI
15 Reeves PG, Nielsen FH, Fahey GC Jr. 1993. AIN-93-purified diets for laboratory rodents: Final report of the American institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 123: 1939-1951.   DOI
16 Ross R. 1993. The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature 362: 801-809.   DOI
17 Ryoo R, Sou HD, Ka KH, Park H. 2013. Phylogenetic relationships of Korean Sparassis latifolia based on morphological and ITS rDNA characteristics. J Microbiol 51: 43-48.   DOI
18 Takeyama A, Nagata Y, Shirouchi B, Nonaka C, Aoki H, Haraguchi T, Sato M, Tamaya K, Yamamoto, H, Tanaka K. 2018. Dietary Sparassis crispa reduces body fat mass and hepatic lipid levels by enhancing energy expenditure and suppressing lipogenesis in rats. J Oleo Sci 67: 1137-1147.   DOI
19 Wasser SP. 2014. Medicinal mushroom science: Current perspectives, advances, evidences, and challenges. Biomed J 37: 345-356   DOI
20 Yoon KN, Alam N, Shim MJ, Lee TS. 2012. Hypolipidemic and antiatherogenesis effect of culinary-medicinal pink oyster mushroom, Pleurotus salmoneostramineus L. Vass. (higher basidiomycetes), in rats. Int J Med Mushrooms 14: 27-36.   DOI
21 Yoon KN, Lee JS, Kim HY, Lee KR, Shin PG, Cheong JC, Yoo YB, Alam N, Ha TM, Lee TS. 2011. Appraisal of antihyperlipidemic activities of Lentinus lepideus in hypercholesterolemic rats. Mycobiol 39: 283-289.   DOI
22 Zou Y, Li J, Lu C, Wang J, Ge J, Huang Y, Zhang L, Wang Y. 2006. High-fat emulsion induced rat model of nonalcoholic steatohepatitis. Life Sci 79: 1100-1107.   DOI
23 Chandrasekaran G, Oh DS, Shin HJ. 2011. Properties and potential applications of the culinary-medicinal cauliflower mushroom, Sparassis crispa Wulf.:Fr. (Aphyllophoromycetideae): A review. Int J Med Mushrooms 13: 177-183.   DOI
24 Agah HM, Alipour A, Janbozorgi M, Hajihosseini R, Shaghaghi F, Golchin N, Nouhi S. 2013. Lipid profile improvement after four group psychological interventions in combination to nutritional and physical activity instructing among overweight and obese individuals. Iran J Public Health 42: 86-95.
25 Alam N, Yoon KN, Lee TS, Lee UY. 2011. Hypolipidemic activities of dietary Pleurotus ostreatus in hypercholesterolemic rats. Mycobiol 39: 45-51.   DOI
26 Cannon CP. 2007. Cardiovascular disease and modifiable cardiometabolic risk factors. Clin Cornerstone 8: 11-28.   DOI
27 Cheung PCK. 1996. The hypercholesterolemic effect of two edible mushrooms: Auricularia auricula (tree-ear) and Tremella fuciformis (white jelly-leaf) in hypercholesterolemic rats. Nutr Res 16: 1721-1725.   DOI
28 Kim GY, Jung HW, Kim EJ. 2013. Anti-hyperlipidemic effect of shiitake mushroom extract in hyperlipidemic rats induced by Poloxamer-407. Korean J Orient Pathol 27: 409-415.
29 Haglund O, Loustarinen R, Wallin R, Wibell I, Saldeen T. 1991. The effect of oil on triglycerides, cholesterol, fibrinogen and malondialdehyde in humans supplemented with vitamin E. J Nutr 121(2): 165-169.   DOI
30 Jones P, Kafonek S, Laurora I, Hunninghake D. 1998. Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study). Am J Cardiol 81: 582-587.   DOI
31 Kim JH, Son IS, Kim JS, Kim KH, Kwon CS. 2008. Lipase inhibitory and anti-oxidative activity of the methanol extract and the powder of Phellinus linteus. J Korean Soc Food Sci Nutr 37: 154-161.   DOI
32 Kobayashi H, Matsushita M, Oda K, Nishikimi N, Sakuri T, Komori K. 2004. Effect of atherosclerotic plaque on the enlargement of an experimental model of abdominal aortic aneurysm in rabbits. Eur J Vasc Endovasc Surg 28: 71-78.   DOI
33 Mattilda P, Suonpaa K, Piironen V. 2000. Functional properties of edible mushrooms. Nutrition 16: 694-696.   DOI
34 Manzi P, Pizzoferrato L. 2000. Beta-glucans in edible mushrooms. Food Chem 68: 315-318.   DOI
35 McFarlane SI, Muniyappa R, Francisco R, Sowers JR. 2002. Clinical review 145: Pleiotropic effects of statins: lipid reduction and beyond. J Clin Endocrinol Metab 87: 1451-1458.   DOI
36 Mattilda P, Konko K, Eurola M, Pihlava JM, Astola J, Vahteristo L. 2001. Contents of vitamins, mineral elements, and some phenolic compounds in cultivated mushrooms. J Agric Food Chem 49: 2343-2348.   DOI
37 Molitoris HP. 1994. Mushrooms in medicine. Folia Microbiol 9: 91-98.   DOI